Erythema multiforme; Toxic epidermal necrolysis — VA Rating Criteria (38 CFR DC 7827)

The VA rates Erythema multiforme; Toxic epidermal necrolysis under Diagnostic Code 7827 at the following tiers: 10%, 30%, 60%. The minimum 10% rating requires: At least one of the following. The maximum 60% rating requires: Recurrent mucosal, palmar, or plantar involvement impairing mastication, use of hands, or ambulation occurring four or more times over the past 12-month period despite ongoing immunosuppressive therapy.

Diagnostic Code 7827 is the VA rating identifier for Erythema multiforme; Toxic epidermal necrolysis within 38 CFR 38 CFR § 4.118. It defines the specific symptom criteria and percentage thresholds a VA adjudicator uses to assign a disability rating. The diagnostic code is listed on a veteran's rating decision letter.

The highest schedular rating for Erythema multiforme; Toxic epidermal necrolysis under DC 7827 is 60%. This tier requires: Recurrent mucosal, palmar, or plantar involvement impairing mastication, use of hands, or ambulation occurring four or more times over the past 12-month period despite ongoing immunosuppressive therapy. Veterans who cannot secure substantially gainful employment due to Erythema multiforme; Toxic epidermal necrolysis alone or in combination with other service-connected conditions may also qualify for TDIU at the 100% compensation rate under 38 CFR § 4.16.

Erythema multiforme; Toxic epidermal necrolysis is rated under 38 CFR 38 CFR § 4.118, Diagnostic Code 7827. This section is part of the Schedule for Rating Disabilities (38 CFR Part 4) and can be read in full at the eCFR website.

Secondary conditions caused or aggravated by Erythema multiforme; Toxic epidermal necrolysis may be ratable under 38 CFR § 3.310. Veterans should work with a VSO or accredited claims agent to document the medical relationship.

Service connection for Erythema multiforme; Toxic epidermal necrolysis requires three elements: (1) a current diagnosis of the condition, (2) an in-service event, injury, or disease that may have caused or aggravated it, and (3) a medical nexus connecting the current diagnosis to that in-service event. A nexus letter from a treating physician or independent medical examiner is the most reliable nexus evidence. C&P exam findings can also establish nexus if adequately documented.